FORM OF PRESENTATION FOR 3-((2-{(4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)-PHENYLAMINO)-METHYL}-1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)-PYRIDIN-2-YL-AMINO) PROPIONIC ACID ETHYL ESTER TO BE ADMINISTERED ORALLY
Oppfinnelsen angår en ny administreringsform for oral anvendelse av den aktive substans etyl-3-[(2-{[4-(heksyloksykarbonylamin-imin-metyl)-fenylamin]-metyl}-1-metyl-1H-benzimidazol-5-karbonyl)-pyridin-2-yl-amin]-propionat og farmakologisk akseptable salter derav. 1